RIVAROXABAN
| Brand name | XARELTO |
|---|---|
| Active ingredient | RIVAROXABAN |
| Strength | 10MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2011 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9539218*PED | August 2034 | — |
| 9539218 | February 2034 | use U-3288 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.